Sunday, January 23, 2022  | 19 Jamadilakhir, 1443
Samaa TV
Facebook Twitter Youtube
HOME > Video

Pakistan starts Actemra drug trials on coronavirus patients

They are being conducted in selected public and private hospitals

SAMAA | - Posted: Jun 13, 2020 | Last Updated: 2 years ago
SAMAA |
Posted: Jun 13, 2020 | Last Updated: 2 years ago

Clinical trials of the anti-inflammatory drug tocilizumab (Actemra) for COVID-19 have begun in selected public and private hospitals in Punjab.

Tocilizumab is immunosuppressive drug used for rheumatoid arthritis. It works by decreasing the severity of the immune response known as a cytokine storm.
FaceBook WhatsApp
 
HOME  
 
 

Tell us what you think:

Your email address will not be published.

FaceBook WhatsApp
 

 
 
 

MOST READ
MOST READ
SAMAA TV News Headlines 12am – 22 January 2022
SAMAA TV News Headlines 9pm – 21 January 2022
SAMAA TV News Headlines 6pm – 22 January 2022
SAMAA TV News Headlines 9pm – 22 January 2022
SAMAA TV News Headlines 9am – 22 January 2022
SAMAA TV News Headlines 3pm – 22 January 2022
SAMAA TV News Headlines 12pm – 22 January 2022
 
 
 
 
 
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp